Skip to main content
Signal8

Hirsch Scott

SEC insider (Form 3/4/5 filer). CIK 0002024619. Director at Keenova Therapeutics plc (NONE). 6 reported Form 4/5 transactions since Sep 2024; latest on Jul 15, 2026. Located in BRIDGEWATER, NJ.

Companies Hirsch Scott has filed insider reports for

  • Keenova Therapeutics plc (NONE): Director
Hirsch Scott profile photo

Hirsch Scott

CIK: 0002024619

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)1 (16.7%)

Derivative conversions

Awards (A)3 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)2 (33.3%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Keenova Therapeutics plc logo
NONE

Keenova Therapeutics plc

Director

Discretionary Trading P&L

Holdings

Transaction History (6 total)

  • Keenova Therapeutics plc logo
    No ticker

    Keenova Therapeutics plc

    Jul 15, 2026
    Award

    Restricted Stock Units

    Direct
    4.4K shares-
  • Keenova Therapeutics plc logo
    No ticker

    Keenova Therapeutics plc

    Jun 2, 2026
    Exercise
    Direct
    2.7K shares-
  • Keenova Therapeutics plc logo
    No ticker

    Keenova Therapeutics plc

    Jun 2, 2026
    Tax Payment
    Direct
    619 shares-
  • Keenova Therapeutics plc logo
    No ticker

    Keenova Therapeutics plc

    Jun 2, 2026
    Disposition

    Restricted Stock Units

    Direct
    2.2K shares-
  • Keenova Therapeutics plc logo
    No ticker

    Keenova Therapeutics plc

    Feb 23, 2026
    Award

    Restricted Stock Units

    Direct
    4K shares-
  • No ticker

    Mallinckrodt plc

    Aug 14, 2025
    Award

    Restricted Stock Units

    Direct
    4.1K shares-

1-6 of 6